Quick Summary:
In the ever-evolving healthcare industry, staying ahead of key trends and innovations is paramount. The global Monocyte Activation Tests market is steadily gaining traction, triggering a need for comprehensive insights into this emerging sector. Predicted to escalate from US$10.8 Million in 2022 to a robust US$29.8 Million by 2030, this market presents an array of opportunities for informed decision-making and strategic investments.
Detailed analysis of the significant segments and geographies, such as the high-potential U.S. and Chinese markets, is paramount in today’s competitive landscape. Our meticulous report also delves into the performance of key competitors - from Becton, Dickinson & Company to Thermo Fisher Scientific, Inc. Capitalize on our exclusive digital resources and benefit from complimentary updates for one year, to stay informed about all essential developments. This market research report is your roadmap to navigate the promising arena of Monocyte Activation Tests with confidence and acumen.
Global Monocyte Activation Tests Market to Reach $29.8 Million by 2030
The global market for Monocyte Activation Tests estimated at US$10.8 Million in the year 2022, is projected to reach a revised size of US$29.8 Million by 2030, growing at a CAGR of 13.5% over the analysis period 2022-2030. Monocyte Activation Test Kits, one of the segments analyzed in the report, is projected to record 14.7% CAGR and reach US$16.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Reagents segment is readjusted to a revised 12.2% CAGR for the next 8-year period.
The U.S. Market is Estimated at $3.3 Million, While China is Forecast to Grow at 12.9% CAGR
The Monocyte Activation Tests market in the U.S. is estimated at US$3.3 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$5.1 Million by the year 2030 trailing a CAGR of 12.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.1% and 11.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.Select Competitors (Total 41 Featured) -
- Becton, Dickinson & Company
- Charles River Laboratories International, Inc.
- Lonza Group AG
- Merck KgaA
- Microcoat Biotechnologie GmbH
- Sanquin
- Solvias AG
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Monocyte Activation Tests?
What is the growth rate of the Global Market for Monocyte Activation Tests?
What is the forecasted size of the Global Market for Monocyte Activation Tests?
Who are the key companies in the Global Market for Monocyte Activation Tests?
| Report Attribute | Details |
|---|---|
| No. of Pages | 244 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 10.8 Million |
| Forecasted Market Value ( USD | $ 29.8 Million |
| Compound Annual Growth Rate | 13.5% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Becton, Dickinson & Company
- Charles River Laboratories International, Inc.
- Lonza Group AG
- Merck KgaA
- Microcoat Biotechnologie GmbH
- Sanquin
- Solvias AG
- Thermo Fisher Scientific, Inc.
